-
1
-
-
0001596943
-
The biochemistry and the physiological and molecular actions of jasmonates
-
10.1146/annurev.pp.44.060193.003033 1:CAS:528:DyaK3sXltlGmtrk%3D
-
Sembdner G, Parthier B (1993) The biochemistry and the physiological and molecular actions of jasmonates. Annu Rev Plant Physiol Plant Mol Biol 44:569-589
-
(1993)
Annu Rev Plant Physiol Plant Mol Biol
, vol.44
, pp. 569-589
-
-
Sembdner, G.1
Parthier, B.2
-
2
-
-
0345950223
-
Biosynthesis and action of jasmonates in plants
-
10.1146/annurev.arplant.48.1.355 1:CAS:528:DyaK2sXjs1enu7s%3D
-
Creelman RA, Mullet JE (1997) Biosynthesis and action of jasmonates in plants. Annu Rev Plant Physiol Plant Mol Biol 48:355-381
-
(1997)
Annu Rev Plant Physiol Plant Mol Biol
, vol.48
, pp. 355-381
-
-
Creelman, R.A.1
Mullet, J.E.2
-
3
-
-
34848897179
-
Jasmonates: An update on biosynthesis, signal transduction and action in plant stress response, growth and development
-
10.1093/aob/mcm079 1:CAS:528:DC%2BD2sXhtlyhs7vF
-
Wasternack C (2007) Jasmonates: an update on biosynthesis, signal transduction and action in plant stress response, growth and development. Ann Bot 100(4):681-697
-
(2007)
Ann Bot
, vol.100
, Issue.4
, pp. 681-697
-
-
Wasternack, C.1
-
5
-
-
0030467334
-
Systemic acquired resistance
-
1:CAS:528:DyaK28Xmsl2murw%3D
-
Ryals JA, Neuenschwander UH, Willits MG, Molina A, Steiner HY, Hunt MD (1996) Systemic acquired resistance. Plant Cell 8(10):1809-1819
-
(1996)
Plant Cell
, vol.8
, Issue.10
, pp. 1809-1819
-
-
Ryals, J.A.1
Neuenschwander, U.H.2
Willits, M.G.3
Molina, A.4
Steiner, H.Y.5
Hunt, M.D.6
-
6
-
-
31644444385
-
Fine-tuning plant defence signalling: Salicylate versus jasmonate
-
10.1055/s-2005-872705 1:CAS:528:DC%2BD28XjtlWksLo%3D
-
Beckers GJ, Spoel SH (2006) Fine-tuning plant defence signalling: salicylate versus jasmonate. Plant Biol (Stuttg) 8(1):1-10
-
(2006)
Plant Biol (Stuttg)
, vol.8
, Issue.1
, pp. 1-10
-
-
Beckers, G.J.1
Spoel, S.H.2
-
7
-
-
70350489457
-
Jasmonate signaling in plant interactions with resistance-inducing beneficial microbes
-
Van der Ent S, Van Wees SC, Pieterse CM (2009) Jasmonate signaling in plant interactions with resistance-inducing beneficial microbes. Phytochemistry 70(13-14):1581-1588
-
(2009)
Phytochemistry
, vol.70
, Issue.13-14
, pp. 1581-1588
-
-
Van Der Ent, S.1
Van Wees, S.C.2
Pieterse, C.M.3
-
8
-
-
0141574408
-
Regulation of jasmonate-mediated plant responses in arabidopsis
-
10.1093/aob/mcg151 1:CAS:528:DC%2BD3sXnvVShsL4%3D
-
Devoto A, Turner JG (2003) Regulation of jasmonate-mediated plant responses in arabidopsis. Ann Bot 92(3):329-337
-
(2003)
Ann Bot
, vol.92
, Issue.3
, pp. 329-337
-
-
Devoto, A.1
Turner, J.G.2
-
9
-
-
33746442874
-
Identification of genes of the plant-specific transcription-factor families cooperatively regulated by ethylene and jasmonate in Arabidopsis thaliana
-
10.1007/s10265-006-0287-x 1:CAS:528:DC%2BD28Xnt1agtLs%3D
-
Nakano T, Suzuki K, Ohtsuki N, Tsujimoto Y, Fujimura T, Shinshi H (2006) Identification of genes of the plant-specific transcription-factor families cooperatively regulated by ethylene and jasmonate in Arabidopsis thaliana. J Plant Res 119(4):407-413
-
(2006)
J Plant Res
, vol.119
, Issue.4
, pp. 407-413
-
-
Nakano, T.1
Suzuki, K.2
Ohtsuki, N.3
Tsujimoto, Y.4
Fujimura, T.5
Shinshi, H.6
-
10
-
-
65749114304
-
Jasmonate- and salicylate-mediated plant defense responses to insect herbivores, pathogens and parasitic plants
-
10.1002/ps.1714 1:CAS:528:DC%2BD1MXlsFymurY%3D
-
Smith JL, De Moraes CM, Mescher MC (2009) Jasmonate- and salicylate-mediated plant defense responses to insect herbivores, pathogens and parasitic plants. Pest Manag Sci 65(5):497-503
-
(2009)
Pest Manag Sci
, vol.65
, Issue.5
, pp. 497-503
-
-
Smith, J.L.1
De Moraes, C.M.2
Mescher, M.C.3
-
11
-
-
11944254202
-
Interplant communication: Airborne methyl jasmonate induces synthesis of proteinase inhibitors in plant leaves
-
10.1073/pnas.87.19.7713 1:CAS:528:DyaK3MXjs1Sm
-
Farmer EE, Ryan CA (1990) Interplant communication: airborne methyl jasmonate induces synthesis of proteinase inhibitors in plant leaves. Proc Natl Acad Sci USA 87(19):7713-7716
-
(1990)
Proc Natl Acad Sci USA
, vol.87
, Issue.19
, pp. 7713-7716
-
-
Farmer, E.E.1
Ryan, C.A.2
-
12
-
-
47249114779
-
Methyl jasmonate induces production of reactive oxygen species and alterations in mitochondrial dynamics that precede photosynthetic dysfunction and subsequent cell death
-
10.1093/pcp/pcn086 1:CAS:528:DC%2BD1cXpvVOntr0%3D
-
Zhang L, Xing D (2008) Methyl jasmonate induces production of reactive oxygen species and alterations in mitochondrial dynamics that precede photosynthetic dysfunction and subsequent cell death. Plant Cell Physiol 49(7):1092-1111
-
(2008)
Plant Cell Physiol
, vol.49
, Issue.7
, pp. 1092-1111
-
-
Zhang, L.1
Xing, D.2
-
13
-
-
33845642967
-
Jasmonates in cancer therapy
-
10.1016/j.canlet.2006.03.001 1:CAS:528:DC%2BD2sXht1eitA%3D%3D
-
Flescher E (2007) Jasmonates in cancer therapy. Cancer Lett 245(1-2):1-10
-
(2007)
Cancer Lett
, vol.245
, Issue.1-2
, pp. 1-10
-
-
Flescher, E.1
-
14
-
-
70350517590
-
Methyl jasmonate: A plant stress hormone as an anti-cancer drug
-
10.1016/j.phytochem.2009.06.007 1:CAS:528:DC%2BD1MXhtlGiu7fP
-
Cohen S, Flescher E (2009) Methyl jasmonate: a plant stress hormone as an anti-cancer drug. Phytochemistry 70(13-14):1600-1609
-
(2009)
Phytochemistry
, vol.70
, Issue.13-14
, pp. 1600-1609
-
-
Cohen, S.1
Flescher, E.2
-
15
-
-
0036240569
-
Plant stress hormones suppress the proliferation and induce apoptosis in human cancer cells
-
10.1038/sj.leu.2402419 1:CAS:528:DC%2BD38XjvFGmsr4%3D
-
Fingrut O, Flescher E (2002) Plant stress hormones suppress the proliferation and induce apoptosis in human cancer cells. Leukemia 16(4):608-616
-
(2002)
Leukemia
, vol.16
, Issue.4
, pp. 608-616
-
-
Fingrut, O.1
Flescher, E.2
-
16
-
-
26244458767
-
Jasmonates-a new family of anti-cancer agents
-
10.1097/01.cad.0000176501.63680.80 1:CAS:528:DC%2BD2MXpvFOqt7w%3D
-
Flescher E (2005) Jasmonates-a new family of anti-cancer agents. Anticancer Drugs 16(9):911-916
-
(2005)
Anticancer Drugs
, vol.16
, Issue.9
, pp. 911-916
-
-
Flescher, E.1
-
17
-
-
16444376422
-
Jasmonates: Novel anticancer agents acting directly and selectively on human cancer cell mitochondria
-
10.1158/0008-5472.CAN-04-3091 1:CAS:528:DC%2BD2MXitVOjt7s%3D
-
Rotem R, Heyfets A, Fingrut O, Blickstein D, Shaklai M, Flescher E (2005) Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondria. Cancer Res 65(5):1984-1993
-
(2005)
Cancer Res
, vol.65
, Issue.5
, pp. 1984-1993
-
-
Rotem, R.1
Heyfets, A.2
Fingrut, O.3
Blickstein, D.4
Shaklai, M.5
Flescher, E.6
-
18
-
-
27744487132
-
Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells
-
10.1038/sj.bjp.0706394 1:CAS:528:DC%2BD2MXht1Smur%2FM
-
Fingrut O, Reischer D, Rotem R, Goldin N, Altboum I, Zan-Bar I, Flescher E (2005) Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells. Br J Pharmacol 146(6):800-808
-
(2005)
Br J Pharmacol
, vol.146
, Issue.6
, pp. 800-808
-
-
Fingrut, O.1
Reischer, D.2
Rotem, R.3
Goldin, N.4
Altboum, I.5
Zan-Bar, I.6
Flescher, E.7
-
19
-
-
34047168229
-
Cooperative cytotoxicity of methyl jasmonate with anti-cancer drugs and 2-deoxy-d-glucose
-
10.1016/j.canlet.2006.10.013 1:CAS:528:DC%2BD2sXjvFGqur4%3D
-
Heyfets A, Flescher E (2007) Cooperative cytotoxicity of methyl jasmonate with anti-cancer drugs and 2-deoxy-d-glucose. Cancer Lett 250(2):300-310
-
(2007)
Cancer Lett
, vol.250
, Issue.2
, pp. 300-310
-
-
Heyfets, A.1
Flescher, E.2
-
20
-
-
16644392664
-
Methyl jasmonate induces apoptosis through induction of Bax/Bcl-XS and activation of caspase-3 via ROS production in A549 cells
-
1:CAS:528:DC%2BD2MXitFOlsQ%3D%3D
-
Kim JH, Lee SY, Oh SY, Han SI, Park HG, Yoo MA, Kang HS (2004) Methyl jasmonate induces apoptosis through induction of Bax/Bcl-XS and activation of caspase-3 via ROS production in A549 cells. Oncol Rep 12(6):1233-1238
-
(2004)
Oncol Rep
, vol.12
, Issue.6
, pp. 1233-1238
-
-
Kim, J.H.1
Lee, S.Y.2
Oh, S.Y.3
Han, S.I.4
Park, H.G.5
Yoo, M.A.6
Kang, H.S.7
-
21
-
-
36148943488
-
Methyl jasmonate induced apoptosis in human prostate carcinoma cells via 5-lipoxygenase dependent pathway
-
1:CAS:528:DC%2BD2sXhtlyhs7%2FF
-
Ezekwudo DE, Wang RC, Elegbede JA (2007) Methyl jasmonate induced apoptosis in human prostate carcinoma cells via 5-lipoxygenase dependent pathway. J Exp Ther Oncol 6(4):267-277
-
(2007)
J Exp Ther Oncol
, vol.6
, Issue.4
, pp. 267-277
-
-
Ezekwudo, D.E.1
Wang, R.C.2
Elegbede, J.A.3
-
22
-
-
33845796924
-
Jasmonates induce apoptosis and cell cycle arrest in non-small cell lung cancer lines
-
10.1080/01902140601059604 1:CAS:528:DC%2BD2sXhvFSmsb4%3D
-
Yeruva L, Pierre KJ, Carper SW, Elegbede JA, Toy BJ, Wang RC (2006) Jasmonates induce apoptosis and cell cycle arrest in non-small cell lung cancer lines. Exp Lung Res 32(10):499-516
-
(2006)
Exp Lung Res
, vol.32
, Issue.10
, pp. 499-516
-
-
Yeruva, L.1
Pierre, K.J.2
Carper, S.W.3
Elegbede, J.A.4
Toy, B.J.5
Wang, R.C.6
-
23
-
-
53749090929
-
Methyl jasmonate decreases membrane fluidity and induces apoptosis through tumor necrosis factor receptor 1 in breast cancer cells
-
10.1097/CAD.0b013e32830b5894 1:CAS:528:DC%2BD1cXpsFKqtb8%3D
-
Yeruva L, Elegbede JA, Carper SW (2008) Methyl jasmonate decreases membrane fluidity and induces apoptosis through tumor necrosis factor receptor 1 in breast cancer cells. Anticancer Drugs 19(8):766-776
-
(2008)
Anticancer Drugs
, vol.19
, Issue.8
, pp. 766-776
-
-
Yeruva, L.1
Elegbede, J.A.2
Carper, S.W.3
-
24
-
-
57049178439
-
Delayed cytotoxic effects of methyl jasmonate and cis-jasmone induced apoptosis in prostate cancer cells
-
10.1080/07357900801975272 1:CAS:528:DC%2BD1cXhsVCms7%2FJ
-
Yeruva L, Pierre KJ, Bathina M, Elegbede A, Carper SW (2008) Delayed cytotoxic effects of methyl jasmonate and cis-jasmone induced apoptosis in prostate cancer cells. Cancer Invest 26(9):890-899
-
(2008)
Cancer Invest
, vol.26
, Issue.9
, pp. 890-899
-
-
Yeruva, L.1
Pierre, K.J.2
Bathina, M.3
Elegbede, A.4
Carper, S.W.5
-
25
-
-
53749096199
-
Methyl jasmonate downregulates expression of proliferating cell nuclear antigen and induces apoptosis in human neuroblastoma cell lines
-
10.1097/CAD.0b013e3282fc46b0 1:CAS:528:DC%2BD1cXms1yru78%3D
-
Tong QS, Jiang GS, Zheng LD, Tang ST, Cai JB, Liu Y, Zeng FQ, Dong JH (2008) Methyl jasmonate downregulates expression of proliferating cell nuclear antigen and induces apoptosis in human neuroblastoma cell lines. Anticancer Drugs 19(6):573-581
-
(2008)
Anticancer Drugs
, vol.19
, Issue.6
, pp. 573-581
-
-
Tong, Q.S.1
Jiang, G.S.2
Zheng, L.D.3
Tang, S.T.4
Cai, J.B.5
Liu, Y.6
Zeng, F.Q.7
Dong, J.H.8
-
26
-
-
65849284657
-
Natural jasmonates of different structures suppress the growth of human neuroblastoma cell line SH-SY5Y and its mechanisms
-
10.1111/j.1745-7254.2008.00814.x 1:CAS:528:DC%2BD1cXovVSms7Y%3D
-
Tong QS, Jiang GS, Zheng LD, Tang ST, Cai JB, Liu Y, Zeng FQ, Dong JH (2008) Natural jasmonates of different structures suppress the growth of human neuroblastoma cell line SH-SY5Y and its mechanisms. Acta Pharmacol Sin 29(7):861-869
-
(2008)
Acta Pharmacol Sin
, vol.29
, Issue.7
, pp. 861-869
-
-
Tong, Q.S.1
Jiang, G.S.2
Zheng, L.D.3
Tang, S.T.4
Cai, J.B.5
Liu, Y.6
Zeng, F.Q.7
Dong, J.H.8
-
27
-
-
52449095786
-
Inhibition of expression of anti-apoptotic protein Bcl-2 and induction of cell death in radioresistant human prostate adenocarcinoma cell line (PC-3) by methyl jasmonate
-
10.1016/j.canlet.2008.05.022 1:CAS:528:DC%2BD1cXhtFekt77L
-
Ezekwudo D, Shashidharamurthy R, Devineni D, Bozeman E, Palaniappan R, Selvaraj P (2008) Inhibition of expression of anti-apoptotic protein Bcl-2 and induction of cell death in radioresistant human prostate adenocarcinoma cell line (PC-3) by methyl jasmonate. Cancer Lett 270(2):277-285
-
(2008)
Cancer Lett
, vol.270
, Issue.2
, pp. 277-285
-
-
Ezekwudo, D.1
Shashidharamurthy, R.2
Devineni, D.3
Bozeman, E.4
Palaniappan, R.5
Selvaraj, P.6
-
28
-
-
53049089458
-
Methyl jasmonate induces cell death with mixed characteristics of apoptosis and necrosis in cervical cancer cells
-
10.1016/j.canlet.2008.05.031 1:CAS:528:DC%2BD1cXht1Sis7bO
-
Kniazhanski T, Jackman A, Heyfets A, Gonen P, Flescher E, Sherman L (2008) Methyl jasmonate induces cell death with mixed characteristics of apoptosis and necrosis in cervical cancer cells. Cancer Lett 271(1):34-46
-
(2008)
Cancer Lett
, vol.271
, Issue.1
, pp. 34-46
-
-
Kniazhanski, T.1
Jackman, A.2
Heyfets, A.3
Gonen, P.4
Flescher, E.5
Sherman, L.6
-
29
-
-
84858071650
-
Methyl jasmonate reduces the survival of cervical cancer cells and downregulates HPV E6 and E7, and survivin
-
10.1016/j.canlet.2011.12.028 1:CAS:528:DC%2BC38Xjs1Ggt7Y%3D
-
Milrot E, Jackman A, Kniazhanski T, Gonen P, Flescher E, Sherman L (2012) Methyl jasmonate reduces the survival of cervical cancer cells and downregulates HPV E6 and E7, and survivin. Cancer Lett 319(1):31-38
-
(2012)
Cancer Lett
, vol.319
, Issue.1
, pp. 31-38
-
-
Milrot, E.1
Jackman, A.2
Kniazhanski, T.3
Gonen, P.4
Flescher, E.5
Sherman, L.6
-
30
-
-
0037459081
-
Mitochondria: Releasing power for life and unleashing the machineries of death
-
10.1016/S0092-8674(03)00116-8 1:CAS:528:DC%2BD3sXhs1SnsLs%3D
-
Newmeyer DD, Ferguson-Miller S (2003) Mitochondria: releasing power for life and unleashing the machineries of death. Cell 112(4):481-490
-
(2003)
Cell
, vol.112
, Issue.4
, pp. 481-490
-
-
Newmeyer, D.D.1
Ferguson-Miller, S.2
-
31
-
-
0033079597
-
Oncogenic alterations of metabolism
-
10.1016/S0968-0004(98)01344-9 1:CAS:528:DyaK1MXltFCgsr4%3D
-
Dang CV, Semenza GL (1999) Oncogenic alterations of metabolism. Trends Biochem Sci 24(2):68-72
-
(1999)
Trends Biochem Sci
, vol.24
, Issue.2
, pp. 68-72
-
-
Dang, C.V.1
Semenza, G.L.2
-
32
-
-
0024148694
-
Mitochondrial membrane potential in living cells
-
10.1146/annurev.cb.04.110188.001103 1:CAS:528:DyaL1MXltlSisA%3D%3D
-
Chen LB (1988) Mitochondrial membrane potential in living cells. Annu Rev Cell Biol 4:155-181
-
(1988)
Annu Rev Cell Biol
, vol.4
, pp. 155-181
-
-
Chen, L.B.1
-
33
-
-
33746906633
-
Mitochondria in cancer
-
10.1038/sj.onc.1209589 1:CAS:528:DC%2BD28Xnsl2hs70%3D
-
Kroemer G (2006) Mitochondria in cancer. Oncogene 25(34):4630-4632
-
(2006)
Oncogene
, vol.25
, Issue.34
, pp. 4630-4632
-
-
Kroemer, G.1
-
34
-
-
34249945104
-
The cancer cell's "power plants" as promising therapeutic targets: An overview
-
10.1007/s10863-007-9070-5 1:CAS:528:DC%2BD2sXmtFentr8%3D
-
Pedersen PL (2007) The cancer cell's "power plants" as promising therapeutic targets: an overview. J Bioenerg Biomembr 39(1):1-12
-
(2007)
J Bioenerg Biomembr
, vol.39
, Issue.1
, pp. 1-12
-
-
Pedersen, P.L.1
-
35
-
-
77649187905
-
The Warburg effect and mitochondrial stability in cancer cells
-
10.1016/j.mam.2009.12.004
-
Gogvadze V, Zhivotovsky B, Orrenius S (2009) The Warburg effect and mitochondrial stability in cancer cells. Mol Aspects Med 31(1):60-74
-
(2009)
Mol Aspects Med
, vol.31
, Issue.1
, pp. 60-74
-
-
Gogvadze, V.1
Zhivotovsky, B.2
Orrenius, S.3
-
36
-
-
12444279265
-
On the origin of cancer cells
-
10.1126/science.123.3191.309 1:STN:280:DyaG28%2FltV2ktQ%3D%3D
-
Warburg O (1956) On the origin of cancer cells. Science 123(3191):309-314
-
(1956)
Science
, vol.123
, Issue.3191
, pp. 309-314
-
-
Warburg, O.1
-
37
-
-
0037069929
-
Chemotherapy: Targeting the mitochondrial cell death pathway
-
10.1038/sj.onc.1206039 1:CAS:528:DC%2BD38XpsFShurc%3D
-
Debatin KM, Poncet D, Kroemer G (2002) Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene 21(57):8786-8803
-
(2002)
Oncogene
, vol.21
, Issue.57
, pp. 8786-8803
-
-
Debatin, K.M.1
Poncet, D.2
Kroemer, G.3
-
38
-
-
20344385260
-
Targeting apoptosis pathways in cancer therapy
-
10.3322/canjclin.55.3.178
-
Ghobrial IM, Witzig TE, Adjei AA (2005) Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 55(3):178-194
-
(2005)
CA Cancer J Clin
, vol.55
, Issue.3
, pp. 178-194
-
-
Ghobrial, I.M.1
Witzig, T.E.2
Adjei, A.A.3
-
39
-
-
0037056002
-
Mitochondrial bound type II hexokinase: A key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention
-
1:CAS:528:DC%2BD38Xms1yhtr8%3D
-
Pedersen PL, Mathupala S, Rempel A, Geschwind JF, Ko YH (2002) Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim Biophys Acta 1555(1-3):14-20
-
(2002)
Biochim Biophys Acta
, vol.1555
, Issue.1-3
, pp. 14-20
-
-
Pedersen, P.L.1
Mathupala, S.2
Rempel, A.3
Geschwind, J.F.4
Ko, Y.H.5
-
40
-
-
0022595453
-
Hexokinase receptor complex in hepatoma mitochondria: Evidence from N, N'-dicyclohexylcarbodiimide-labeling studies for the involvement of the pore-forming protein VDAC
-
10.1021/bi00353a010 1:CAS:528:DyaL28XhtVOitbc%3D
-
Nakashima RA, Mangan PS, Colombini M, Pedersen PL (1986) Hexokinase receptor complex in hepatoma mitochondria: evidence from N, N'- dicyclohexylcarbodiimide-labeling studies for the involvement of the pore-forming protein VDAC. Biochemistry 25(5):1015-1021
-
(1986)
Biochemistry
, vol.25
, Issue.5
, pp. 1015-1021
-
-
Nakashima, R.A.1
Mangan, P.S.2
Colombini, M.3
Pedersen, P.L.4
-
41
-
-
0042575733
-
High aerobic glycolysis of rat hepatoma cells in culture: Role of mitochondrial hexokinase
-
10.1073/pnas.74.9.3735 1:CAS:528:DyaE2sXlvVahsr4%3D
-
Bustamante E, Pedersen PL (1977) High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase. Proc Natl Acad Sci USA 74(9):3735-3739
-
(1977)
Proc Natl Acad Sci USA
, vol.74
, Issue.9
, pp. 3735-3739
-
-
Bustamante, E.1
Pedersen, P.L.2
-
42
-
-
33746924468
-
Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria
-
10.1038/sj.onc.1209603 1:CAS:528:DC%2BD28Xnsl2hsLo%3D
-
Mathupala SP, Ko YH, Pedersen PL (2006) Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 25(34):4777-4786
-
(2006)
Oncogene
, vol.25
, Issue.34
, pp. 4777-4786
-
-
Mathupala, S.P.1
Ko, Y.H.2
Pedersen, P.L.3
-
43
-
-
35448964610
-
Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "warburg Effect", i.e., elevated glycolysis in the presence of oxygen
-
10.1007/s10863-007-9094-x 1:CAS:528:DC%2BD2sXhtF2iu7zP
-
Pedersen PL (2007) Warburg, me and Hexokinase 2: multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr 39(3):211-222
-
(2007)
J Bioenerg Biomembr
, vol.39
, Issue.3
, pp. 211-222
-
-
Pedersen, P.L.1
-
44
-
-
47749093652
-
Methyl jasmonate binds to and detaches mitochondria-bound hexokinase
-
10.1038/onc.2008.108 1:CAS:528:DC%2BD1cXptlKntrw%3D
-
Goldin N, Arzoine L, Heyfets A, Israelson A, Zaslavsky Z, Bravman T, Bronner V, Notcovich A, Shoshan-Barmatz V, Flescher E (2008) Methyl jasmonate binds to and detaches mitochondria-bound hexokinase. Oncogene 27(34):4636-4643
-
(2008)
Oncogene
, vol.27
, Issue.34
, pp. 4636-4643
-
-
Goldin, N.1
Arzoine, L.2
Heyfets, A.3
Israelson, A.4
Zaslavsky, Z.5
Bravman, T.6
Bronner, V.7
Notcovich, A.8
Shoshan-Barmatz, V.9
Flescher, E.10
-
45
-
-
49149087268
-
Disruption of the hexokinase-VDAC complex for tumor therapy
-
10.1038/onc.2008.114 1:CAS:528:DC%2BD1cXptlKntr0%3D
-
Galluzzi L, Kepp O, Tajeddine N, Kroemer G (2008) Disruption of the hexokinase-VDAC complex for tumor therapy. Oncogene 27(34):4633-4635
-
(2008)
Oncogene
, vol.27
, Issue.34
, pp. 4633-4635
-
-
Galluzzi, L.1
Kepp, O.2
Tajeddine, N.3
Kroemer, G.4
-
46
-
-
55849112650
-
PI3 K/Akt pathway activation attenuates the cytotoxic effect of methyl jasmonate toward sarcoma cells
-
1:CAS:528:DC%2BD1cXhtlagtr3J
-
Elia U, Flescher E (2008) PI3 K/Akt pathway activation attenuates the cytotoxic effect of methyl jasmonate toward sarcoma cells. Neoplasia 10(11):1303-1313
-
(2008)
Neoplasia
, vol.10
, Issue.11
, pp. 1303-1313
-
-
Elia, U.1
Flescher, E.2
-
47
-
-
51849111556
-
PI3 K pathway alterations in cancer: Variations on a theme
-
10.1038/onc.2008.245 1:CAS:528:DC%2BD1cXhtFWiurzI
-
Yuan TL, Cantley LC (2008) PI3 K pathway alterations in cancer: variations on a theme. Oncogene 27(41):5497-5510
-
(2008)
Oncogene
, vol.27
, Issue.41
, pp. 5497-5510
-
-
Yuan, T.L.1
Cantley, L.C.2
-
48
-
-
68249093818
-
Targeting the phosphoinositide 3-kinase pathway in cancer
-
10.1038/nrd2926 1:CAS:528:DC%2BD1MXpt1Wgtb4%3D
-
Liu P, Cheng H, Roberts TM, Zhao JJ (2009) Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 8(8):627-644
-
(2009)
Nat Rev Drug Discov
, vol.8
, Issue.8
, pp. 627-644
-
-
Liu, P.1
Cheng, H.2
Roberts, T.M.3
Zhao, J.J.4
-
49
-
-
0036968347
-
Activation of the PI3 K/Akt pathway and chemotherapeutic resistance
-
10.1016/S1368-7646(02)00120-6 1:CAS:528:DC%2BD3sXhtlShtbg%3D
-
West KA, Castillo SS, Dennis PA (2002) Activation of the PI3 K/Akt pathway and chemotherapeutic resistance. Drug Resist Updat 5(6):234-248
-
(2002)
Drug Resist Updat
, vol.5
, Issue.6
, pp. 234-248
-
-
West, K.A.1
Castillo, S.S.2
Dennis, P.A.3
-
50
-
-
77950914672
-
PI3 K/Akt signalling pathway specific inhibitors: A novel strategy to sensitize cancer cells to anti-cancer drugs
-
10.2174/138161210791033950 1:CAS:528:DC%2BC3cXlvFynsrk%3D
-
Falasca M (2010) PI3 K/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anti-cancer drugs. Curr Pharm Des 16(12):1410-1416
-
(2010)
Curr Pharm des
, vol.16
, Issue.12
, pp. 1410-1416
-
-
Falasca, M.1
-
51
-
-
0141863388
-
Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival
-
10.1128/MCB.23.20.7315-7328.2003 1:CAS:528:DC%2BD3sXotVSru70%3D
-
Rathmell JC, Fox CJ, Plas DR, Hammerman PS, Cinalli RM, Thompson CB (2003) Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol Cell Biol 23(20):7315-7328
-
(2003)
Mol Cell Biol
, vol.23
, Issue.20
, pp. 7315-7328
-
-
Rathmell, J.C.1
Fox, C.J.2
Plas, D.R.3
Hammerman, P.S.4
Cinalli, R.M.5
Thompson, C.B.6
-
52
-
-
0034983918
-
Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase
-
10.1101/gad.889901 1:CAS:528:DC%2BD3MXktlSntbc%3D
-
Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N (2001) Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev 15(11):1406-1418
-
(2001)
Genes Dev
, vol.15
, Issue.11
, pp. 1406-1418
-
-
Gottlob, K.1
Majewski, N.2
Kennedy, S.3
Kandel, E.4
Robey, R.B.5
Hay, N.6
-
53
-
-
9744221185
-
Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak
-
10.1016/j.molcel.2004.11.014 1:CAS:528:DC%2BD2cXhtFaku7zF
-
Majewski N, Nogueira V, Bhaskar P, Coy PE, Skeen JE, Gottlob K, Chandel NS, Thompson CB, Robey RB, Hay N (2004) Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell 16(5):819-830
-
(2004)
Mol Cell
, vol.16
, Issue.5
, pp. 819-830
-
-
Majewski, N.1
Nogueira, V.2
Bhaskar, P.3
Coy, P.E.4
Skeen, J.E.5
Gottlob, K.6
Chandel, N.S.7
Thompson, C.B.8
Robey, R.B.9
Hay, N.10
-
54
-
-
0347986675
-
Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases
-
10.1128/MCB.24.2.730-740.2004 1:CAS:528:DC%2BD2cXktVyluw%3D%3D
-
Majewski N, Nogueira V, Robey RB, Hay N (2004) Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases. Mol Cell Biol 24(2):730-740
-
(2004)
Mol Cell Biol
, vol.24
, Issue.2
, pp. 730-740
-
-
Majewski, N.1
Nogueira, V.2
Robey, R.B.3
Hay, N.4
-
55
-
-
33644635986
-
Induction of heat shock protein 72 in C6 glioma cells by methyl jasmonate through ROS-dependent heat shock factor 1 activation
-
1:CAS:528:DC%2BD2MXhtFygsr7L
-
Oh SY, Kim JH, Park MJ, Kim SM, Yoon CS, Joo YM, Park JS, Han SI, Park HG, Kang HS (2005) Induction of heat shock protein 72 in C6 glioma cells by methyl jasmonate through ROS-dependent heat shock factor 1 activation. Int J Mol Med 16(5):833-839
-
(2005)
Int J Mol Med
, vol.16
, Issue.5
, pp. 833-839
-
-
Oh, S.Y.1
Kim, J.H.2
Park, M.J.3
Kim, S.M.4
Yoon, C.S.5
Joo, Y.M.6
Park, J.S.7
Han, S.I.8
Park, H.G.9
Kang, H.S.10
-
56
-
-
66349108684
-
AKR1C isoforms represent a novel cellular target for jasmonates alongside their mitochondrial-mediated effects
-
10.1158/0008-5472.CAN-08-4533 1:CAS:528:DC%2BD1MXmsFGlu78%3D
-
Davies NJ, Hayden RE, Simpson PJ, Birtwistle J, Mayer K, Ride JP, Bunce CM (2009) AKR1C isoforms represent a novel cellular target for jasmonates alongside their mitochondrial-mediated effects. Cancer Res 69(11):4769-4775
-
(2009)
Cancer Res
, vol.69
, Issue.11
, pp. 4769-4775
-
-
Davies, N.J.1
Hayden, R.E.2
Simpson, P.J.3
Birtwistle, J.4
Mayer, K.5
Ride, J.P.6
Bunce, C.M.7
-
57
-
-
61649103983
-
Steroid hormone transforming aldo-keto reductases and cancer
-
10.1111/j.1749-6632.2009.03700.x 1:CAS:528:DC%2BD1MXktFKlsb8%3D
-
Penning TM, Byrns MC (2009) Steroid hormone transforming aldo-keto reductases and cancer. Ann N Y Acad Sci 1155:33-42
-
(2009)
Ann N y Acad Sci
, vol.1155
, pp. 33-42
-
-
Penning, T.M.1
Byrns, M.C.2
-
58
-
-
0031759084
-
Identification of a principal mRNA species for human 3alpha- hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketoreductase activity
-
10.1093/oxfordjournals.jbchem.a022211 1:CAS:528:DyaK1MXjvFSqsA%3D%3D
-
Matsuura K, Shiraishi H, Hara A, Sato K, Deyashiki Y, Ninomiya M, Sakai S (1998) Identification of a principal mRNA species for human 3alpha-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketoreductase activity. J Biochem 124(5):940-946
-
(1998)
J Biochem
, vol.124
, Issue.5
, pp. 940-946
-
-
Matsuura, K.1
Shiraishi, H.2
Hara, A.3
Sato, K.4
Deyashiki, Y.5
Ninomiya, M.6
Sakai, S.7
-
59
-
-
9144234163
-
Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions
-
10.1093/carcin/bgh240 1:CAS:528:DC%2BD2cXhtVWgs73P
-
Lan Q, Mumford JL, Shen M, Demarini DM, Bonner MR, He X, Yeager M, Welch R, Chanock S, Tian L, Chapman RS, Zheng T, Keohavong P, Caporaso N, Rothman N (2004) Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions. Carcinogenesis 25(11):2177-2181
-
(2004)
Carcinogenesis
, vol.25
, Issue.11
, pp. 2177-2181
-
-
Lan, Q.1
Mumford, J.L.2
Shen, M.3
Demarini, D.M.4
Bonner, M.R.5
He, X.6
Yeager, M.7
Welch, R.8
Chanock, S.9
Tian, L.10
Chapman, R.S.11
Zheng, T.12
Keohavong, P.13
Caporaso, N.14
Rothman, N.15
-
60
-
-
84878989676
-
-
Cancer Medicine. Cancer Medicine BC Decker
-
Frei E, BasJr RC, Kufe DW, Pollock RE, Weichselbaum RR, Holland JF, Gansler TS (2003) Principles of Dose, Schedule, and Combination Chemotherapy. Cancer Medicine. Cancer Medicine, BC Decker, pp 817-837
-
(2003)
Principles of Dose, Schedule, and Combination Chemotherapy
, pp. 817-837
-
-
Frei, E.1
Basjr, R.C.2
Kufe, D.W.3
Pollock, R.E.4
Weichselbaum, R.R.5
Holland, J.F.6
Gansler, T.S.7
-
61
-
-
77953233238
-
-
A Multidisciplinary Approach. CMP Healthcare Media, Manhasset Cancer Management
-
Takimoto C, Coia LR, Hoskins WJ, Wagman LD (2005) Principles of Oncologic Pharmacotherapy. A Multidisciplinary Approach. CMP Healthcare Media, Manhasset, Cancer Management, pp 23-42
-
(2005)
Principles of Oncologic Pharmacotherapy
, pp. 23-42
-
-
Takimoto, C.1
Coia, L.R.2
Hoskins, W.J.3
Wagman, L.D.4
-
62
-
-
17144431814
-
Mitochondrial targeting of human O6-methylguanine DNA methyltransferase protects against cell killing by chemotherapeutic alkylating agents
-
1:CAS:528:DC%2BD2MXjt1yrsrg%3D
-
Cai S, Xu Y, Cooper RJ, Ferkowicz MJ, Hartwell JR, Pollok KE, Kelley MR (2005) Mitochondrial targeting of human O6-methylguanine DNA methyltransferase protects against cell killing by chemotherapeutic alkylating agents. Cancer Res 65(8):3319-3327
-
(2005)
Cancer Res
, vol.65
, Issue.8
, pp. 3319-3327
-
-
Cai, S.1
Xu, Y.2
Cooper, R.J.3
Ferkowicz, M.J.4
Hartwell, J.R.5
Pollok, K.E.6
Kelley, M.R.7
-
63
-
-
74349110044
-
Perillyl alcohol and methyl jasmonate sensitize cancer cells to cisplatin
-
10.1097/CAD.0b013e32832a68ad 1:CAS:528:DC%2BD1MXhsFWltrbL
-
Yeruva L, Hall C, Elegbede JA, Carper SW (2010) Perillyl alcohol and methyl jasmonate sensitize cancer cells to cisplatin. Anticancer Drugs 21(1):1-9
-
(2010)
Anticancer Drugs
, vol.21
, Issue.1
, pp. 1-9
-
-
Yeruva, L.1
Hall, C.2
Elegbede, J.A.3
Carper, S.W.4
-
64
-
-
80054022978
-
Methyl jasmonate down-regulates survivin expression and sensitizes colon carcinoma cells towards TRAIL-induced cytotoxicity
-
10.1111/j.1476-5381.2011.01419.x 1:CAS:528:DC%2BC3MXhtl2gu7rJ
-
Raviv Z, Zilberberg A, Cohen S, Reischer-Pelech D, Horrix C, Berger MR, Rosin-Arbesfeld R, Flescher E (2011) Methyl jasmonate down-regulates survivin expression and sensitizes colon carcinoma cells towards TRAIL-induced cytotoxicity. Br J Pharmacol 164(5):1433-1444
-
(2011)
Br J Pharmacol
, vol.164
, Issue.5
, pp. 1433-1444
-
-
Raviv, Z.1
Zilberberg, A.2
Cohen, S.3
Reischer-Pelech, D.4
Horrix, C.5
Berger, M.R.6
Rosin-Arbesfeld, R.7
Flescher, E.8
-
65
-
-
77956307170
-
Apoptotic activity of a new jasmonate analogue is associated with its induction of DNA damage
-
1:CAS:528:DC%2BC3cXhtFSkt7%2FK
-
Zhao J, Kang S, Zhang X, You S, Park JS, Jung JH, Kim DK (2010) Apoptotic activity of a new jasmonate analogue is associated with its induction of DNA damage. Oncol Rep 24(3):771-777
-
(2010)
Oncol Rep
, vol.24
, Issue.3
, pp. 771-777
-
-
Zhao, J.1
Kang, S.2
Zhang, X.3
You, S.4
Park, J.S.5
Jung, J.H.6
Kim, D.K.7
-
66
-
-
77957018959
-
A methyl jasmonate derivative, J-7, induces apoptosis in human hepatocarcinoma Hep3B cells in vitro
-
10.1016/j.tiv.2010.08.001 1:CAS:528:DC%2BC3cXht1WltL3O
-
Park C, Jin CY, Kim GY, Cheong J, Jung JH, Yoo YH, Choi YH (2010) A methyl jasmonate derivative, J-7, induces apoptosis in human hepatocarcinoma Hep3B cells in vitro. Toxicol In Vitro 24(7):1920-1926
-
(2010)
Toxicol in Vitro
, vol.24
, Issue.7
, pp. 1920-1926
-
-
Park, C.1
Jin, C.Y.2
Kim, G.Y.3
Cheong, J.4
Jung, J.H.5
Yoo, Y.H.6
Choi, Y.H.7
-
67
-
-
84855353202
-
J7, a methyl jasmonate derivative, enhances TRAIL-mediated apoptosis through up-regulation of reactive oxygen species generation in human hepatoma HepG2 cells
-
10.1016/j.tiv.2011.10.016 1:CAS:528:DC%2BC38XlsFCguw%3D%3D
-
Park C, Jin CY, Hwang HJ, Kim GY, Jung JH, Kim WJ, Yoo YH, Choi YH (2012) J7, a methyl jasmonate derivative, enhances TRAIL-mediated apoptosis through up-regulation of reactive oxygen species generation in human hepatoma HepG2 cells. Toxicol In Vitro 26(1):86-93
-
(2012)
Toxicol in Vitro
, vol.26
, Issue.1
, pp. 86-93
-
-
Park, C.1
Jin, C.Y.2
Hwang, H.J.3
Kim, G.Y.4
Jung, J.H.5
Kim, W.J.6
Yoo, Y.H.7
Choi, Y.H.8
-
68
-
-
14844288360
-
Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: Paving the road to patient-tailored therapy
-
10.1016/j.drup.2004.11.002
-
Van Geelen CM, de Vries EG, de Jong S (2004) Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy. Drug Resist Updat 7(6):345-358
-
(2004)
Drug Resist Updat
, vol.7
, Issue.6
, pp. 345-358
-
-
Van Geelen, C.M.1
De Vries, E.G.2
De Jong, S.3
-
69
-
-
34547819299
-
The promise of TRAIL-potential and risks of a novel anticancer therapy
-
10.1007/s00109-007-0194-1 1:CAS:528:DC%2BD2sXptFehtLc%3D
-
Koschny R, Walczak H, Ganten TM (2007) The promise of TRAIL-potential and risks of a novel anticancer therapy. J Mol Med 85(9):923-935
-
(2007)
J Mol Med
, vol.85
, Issue.9
, pp. 923-935
-
-
Koschny, R.1
Walczak, H.2
Ganten, T.M.3
-
70
-
-
52649109068
-
The TRAIL apoptotic pathway in cancer onset, progression and therapy
-
10.1038/nrc2465 1:CAS:528:DC%2BD1cXhtFCrtbrM
-
Johnstone RW, Frew AJ, Smyth MJ (2008) The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat Rev Cancer 8(10):782-798
-
(2008)
Nat Rev Cancer
, vol.8
, Issue.10
, pp. 782-798
-
-
Johnstone, R.W.1
Frew, A.J.2
Smyth, M.J.3
-
71
-
-
79251600082
-
AN N-terminal Smac peptide sensitizes human prostate carcinoma cells to methyl jasmonate-induced apoptosis
-
10.1016/j.canlet.2010.12.009 1:CAS:528:DC%2BC3MXhtlakur8%3D
-
Jiang G, Zhao J, Xiao X, Tao D, Gu C, Tong Q, Luo B, Wang L, Zeng F (2011) AN N-terminal Smac peptide sensitizes human prostate carcinoma cells to methyl jasmonate-induced apoptosis. Cancer Lett 302(1):37-46
-
(2011)
Cancer Lett
, vol.302
, Issue.1
, pp. 37-46
-
-
Jiang, G.1
Zhao, J.2
Xiao, X.3
Tao, D.4
Gu, C.5
Tong, Q.6
Luo, B.7
Wang, L.8
Zeng, F.9
-
72
-
-
80052469706
-
Predominant enhancement of apoptosis induced by methyl jasmonate in bladder cancer cells: Therapeutic effect of the Antp-conjugated Smac peptide
-
10.1097/CAD.0b013e3283482d40 1:CAS:528:DC%2BC3MXhtVyltbbN
-
Xiao XY, Jiang GS, Wang L, Lv L, Zeng FQ (2011) Predominant enhancement of apoptosis induced by methyl jasmonate in bladder cancer cells: therapeutic effect of the Antp-conjugated Smac peptide. Anticancer Drugs 22(9):853-863
-
(2011)
Anticancer Drugs
, vol.22
, Issue.9
, pp. 853-863
-
-
Xiao, X.Y.1
Jiang, G.S.2
Wang, L.3
Lv, L.4
Zeng, F.Q.5
-
73
-
-
84879551562
-
Enhanced killing of cervical cancer cells by combinations of methyl jasmonate with cisplatin, X or alpha radiation
-
Milrot E, Jackman A, Flescher E, Gonen P, Kelson I, Keisari Y, Sherman L (2012) Enhanced killing of cervical cancer cells by combinations of methyl jasmonate with cisplatin, X or alpha radiation. Invest New Drugs
-
(2012)
Invest New Drugs
-
-
Milrot, E.1
Jackman, A.2
Flescher, E.3
Gonen, P.4
Kelson, I.5
Keisari, Y.6
Sherman, L.7
-
74
-
-
18144434267
-
Cell cycle checkpoint signaling: Cell cycle arrest versus apoptosis
-
10.1016/S0300-483X(02)00460-2
-
Pietenpol JA, Stewart ZA (2002) Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. Toxicology 181-182:475-481
-
(2002)
Toxicology
, vol.181-182
, pp. 475-481
-
-
Pietenpol, J.A.1
Stewart, Z.A.2
-
75
-
-
0038052800
-
Cell cycle and apoptosis
-
10.1046/j.1365-2184.2003.00267.x 1:CAS:528:DC%2BD3sXmtVOitrw%3D
-
Vermeulen K, Berneman ZN, Van Bockstaele DR (2003) Cell cycle and apoptosis. Cell Prolif 36(3):165-175
-
(2003)
Cell Prolif
, vol.36
, Issue.3
, pp. 165-175
-
-
Vermeulen, K.1
Berneman, Z.N.2
Van Bockstaele, D.R.3
-
76
-
-
4344686851
-
Induction of differentiation of human myeloid leukemia cells by jasmonates, plant hormones
-
10.1038/sj.leu.2403421 1:CAS:528:DC%2BD2cXlvVehs7o%3D
-
Ishii Y, Kiyota H, Sakai S, Honma Y (2004) Induction of differentiation of human myeloid leukemia cells by jasmonates, plant hormones. Leukemia 18(8):1413-1419
-
(2004)
Leukemia
, vol.18
, Issue.8
, pp. 1413-1419
-
-
Ishii, Y.1
Kiyota, H.2
Sakai, S.3
Honma, Y.4
-
77
-
-
64849100788
-
Gene expression profiles in differentiating leukemia cells induced by methyl jasmonate are similar to those of cytokinins and methyl jasmonate analogs induce the differentiation of human leukemia cells in primary culture
-
10.1038/leu.2008.347
-
Tsumura H, Akimoto M, Kiyota H, Ishii Y, Ishikura H, Honma Y (2008) Gene expression profiles in differentiating leukemia cells induced by methyl jasmonate are similar to those of cytokinins and methyl jasmonate analogs induce the differentiation of human leukemia cells in primary culture. Leukemia 23(4):753-760
-
(2008)
Leukemia
, vol.23
, Issue.4
, pp. 753-760
-
-
Tsumura, H.1
Akimoto, M.2
Kiyota, H.3
Ishii, Y.4
Ishikura, H.5
Honma, Y.6
-
78
-
-
33947320591
-
Effects of natural and novel synthetic jasmonates in experimental metastatic melanoma
-
10.1038/sj.bjp.0707146 1:CAS:528:DC%2BD2sXjtFCqtL4%3D
-
Reischer D, Heyfets A, Shimony S, Nordenberg J, Kashman Y, Flescher E (2007) Effects of natural and novel synthetic jasmonates in experimental metastatic melanoma. Br J Pharmacol 150(6):738-749
-
(2007)
Br J Pharmacol
, vol.150
, Issue.6
, pp. 738-749
-
-
Reischer, D.1
Heyfets, A.2
Shimony, S.3
Nordenberg, J.4
Kashman, Y.5
Flescher, E.6
-
79
-
-
40549124605
-
Anti-inflammatory constituents of the red alga Gracilaria verrucosa and their synthetic analogues
-
10.1021/np070452q 1:CAS:528:DC%2BD1cXhtFSht7s%3D
-
Dang HT, Lee HJ, Yoo ES, Shinde PB, Lee YM, Hong J, Kim DK, Jung JH (2008) Anti-inflammatory constituents of the red alga Gracilaria verrucosa and their synthetic analogues. J Nat Prod 71(2):232-240
-
(2008)
J Nat Prod
, vol.71
, Issue.2
, pp. 232-240
-
-
Dang, H.T.1
Lee, H.J.2
Yoo, E.S.3
Shinde, P.B.4
Lee, Y.M.5
Hong, J.6
Kim, D.K.7
Jung, J.H.8
-
80
-
-
56349144702
-
New jasmonate analogues as potential anti-inflammatory agents
-
10.1016/j.bmc.2008.10.050 1:CAS:528:DC%2BD1cXhsVajtLbE
-
Dang HT, Lee HJ, Yoo ES, Hong J, Bao B, Choi JS, Jung JH (2008) New jasmonate analogues as potential anti-inflammatory agents. Bioorg Med Chem 16(24):10228-10235
-
(2008)
Bioorg Med Chem
, vol.16
, Issue.24
, pp. 10228-10235
-
-
Dang, H.T.1
Lee, H.J.2
Yoo, E.S.3
Hong, J.4
Bao, B.5
Choi, J.S.6
Jung, J.H.7
-
81
-
-
78651367556
-
Anti-inflammatory effect of methyl dehydrojasmonate (J2) is mediated by the NF-kappaB pathway
-
10.1007/s00109-010-0688-0 1:CAS:528:DC%2BC3MXoslKn
-
Lee HJ, Maeng K, Dang HT, Kang GJ, Ryou C, Jung JH, Kang HK, Prchal JT, Yoo ES, Yoon D (2011) Anti-inflammatory effect of methyl dehydrojasmonate (J2) is mediated by the NF-kappaB pathway. J Mol Med (Berl) 89(1):83-90
-
(2011)
J Mol Med (Berl)
, vol.89
, Issue.1
, pp. 83-90
-
-
Lee, H.J.1
Maeng, K.2
Dang, H.T.3
Kang, G.J.4
Ryou, C.5
Jung, J.H.6
Kang, H.K.7
Prchal, J.T.8
Yoo, E.S.9
Yoon, D.10
-
82
-
-
77954180925
-
In vivo anti-angiogenic effects further support the promise of the antineoplasic activity of methyl jasmonate
-
10.1590/S1519-69842010000200029 1:STN:280:DC%2BC3crgsVKqsQ%3D%3D
-
Pereira Lopes JE, Barbosa MR, Stella CN, Santos WA, Pereira EM, Nogueira-Neto J, Augusto EM, Silva LV, Smaili SS, Gomes LF (2010) In vivo anti-angiogenic effects further support the promise of the antineoplasic activity of methyl jasmonate. Braz J Biol 70(2):443-449
-
(2010)
Braz J Biol
, vol.70
, Issue.2
, pp. 443-449
-
-
Pereira Lopes, J.E.1
Barbosa, M.R.2
Stella, C.N.3
Santos, W.A.4
Pereira, E.M.5
Nogueira-Neto, J.6
Augusto, E.M.7
Silva, L.V.8
Smaili, S.S.9
Gomes, L.F.10
-
83
-
-
79957990169
-
A preliminary study of the local treatment of preneoplastic and malignant skin lesions using methyl jasmonate
-
1:STN:280:DC%2BC3MvnsVWntQ%3D%3D
-
Palmieri B, Iannitti T, Capone S, Flescher E (2011) A preliminary study of the local treatment of preneoplastic and malignant skin lesions using methyl jasmonate. Eur Rev Med Pharmacol Sci 15(3):333-336
-
(2011)
Eur Rev Med Pharmacol Sci
, vol.15
, Issue.3
, pp. 333-336
-
-
Palmieri, B.1
Iannitti, T.2
Capone, S.3
Flescher, E.4
|